| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3345565 | Clinical Microbiology Newsletter | 2007 | 5 Pages |
Abstract
This article attempts to present the backdrop against which Medicare carriers are chartered to make local coverage decisions, and it provides a triangular paradigm for expressing the regulatory, collaborative and evaluative boundaries within which this decision-making takes place. Although infectious disease molecular diagnostic testing will be underscored, this model can be extrapolated to the full complement of Medicare policy issues.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Mitchell I. (Medicare Medical Director),